Welcome to our dedicated page for Natural Health Trends SEC filings (Ticker: NHTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Natural Health Trends Corp’s dependence on Hong Kong direct-selling revenue means digging through hundreds of pages that detail distributor counts, currency risks, and shifting wellness product demand. If you have ever wondered where to find that information—or when executives quietly file Form 4s before a new product 8-K—this page was built for your workflow.
Every submission lands here the instant it posts to EDGAR, then our AI turns dense text into clear language so “Natural Health Trends Corp SEC filings explained simply” is more than a promise. Whether you need the “Natural Health Trends Corp quarterly earnings report 10-Q filing,” want “Natural Health Trends Corp insider trading Form 4 transactions,” or crave a quick “Natural Health Trends Corp earnings report filing analysis,” one click delivers the document and an at-a-glance summary of regional revenue, margin shifts, and cash-flow trends. Real-time alerts cover “Natural Health Trends Corp Form 4 insider transactions real-time,” while side-by-side comparisons reveal how product mix evolves between quarters.
Looking deeper? The “Natural Health Trends Corp proxy statement executive compensation” spotlight breaks down distributor-linked incentives, and our AI highlights any unusual “Natural Health Trends Corp executive stock transactions Form 4.” You’ll also see risk commentary distilled inside each “Natural Health Trends Corp 8-K material events explained,” plus key takeaways from the “Natural Health Trends Corp annual report 10-K simplified.” From monitoring insider sentiment to “understanding Natural Health Trends Corp SEC documents with AI,” this page equips investors, analysts, and compliance teams with fast, accurate insights—no more hunting through sprawling PDFs.
Natural Health Trends Corp. (NHTC) reported a Q3 2025 net loss and lower sales. Net sales were $9.477 million versus $10.691 million a year ago, with a net loss of $431,000 compared to net income of $35,000. Gross profit was $6.987 million and the company posted a loss from operations of $495,000.
For the first nine months, net sales were $30.027 million versus $32.117 million, and net loss was $294,000 versus net income of $396,000. Operating cash flow used was $5.038 million year-to-date. Total assets were $42.251 million as of September 30, 2025, down from $55.359 million at year-end, including cash and cash equivalents of $14.336 million and marketable securities of $17.672 million.
Hong Kong remains the key hub, with substantially all Hong Kong revenue tied to product deliveries to members in China. The company continued its quarterly dividend of $0.20 per share in each of the first three quarters of 2025 and subsequently declared another $0.20 dividend payable on November 28, 2025 to holders of record on November 18, 2025.
Natural Health Trends Corp. filed an 8-K announcing it issued an earnings press release for the quarter ended September 30, 2025. The company furnished the release as Exhibit 99.1.
This is a standard Item 2.02 disclosure providing access to the company’s reported results via the attached press release. Shares trade on Nasdaq under the symbol NHTC.
Natural Health Trends Corp. (NHTC) – Q2 2025 10-Q key takeaways
- Soft top-line: Q2 net sales fell 6% YoY to $9.8 m and H1 sales slipped 4% to $20.6 m, driven by weaker Hong Kong/China demand (83% of revenue).
- Margins resilient: Q2 gross margin held at 73.9% (vs. 74.2% LY) but higher opex kept the company in an $0.3 m operating loss. Net income was a token $15 k (EPS $0.00) vs. $173 k (EPS $0.02) LY.
- Cash drain: H1 operating cash outflow widened to $5.2 m; combined cash & marketable securities dropped to $34.2 m from $43.9 m at YE-24, largely due to $4.6 m in dividends and working-capital uses.
- Balance sheet still debt-free: Total assets $45.2 m, liabilities $16.3 m; equity down to $28.9 m after dividends. Inventories down 15% YTD to $2.8 m as management right-sizes stock.
- Dividend maintained: Paid $0.20 per share in Q1 & Q2; another $0.20 declared 7/28/25 payable 8/22/25. Annualized yield ≈9% at recent prices.
- Concentration & tariff risk: 93% of sales generated outside Americas; 83% routed through HK to China. New U.S./China tariffs, HK political shifts and lack of PRC direct-selling license highlighted as material uncertainties.
Overall: NHTC remains marginally profitable with strong gross margins and no debt, but sustained revenue erosion, negative cash flow and heavy dividend payouts pressure liquidity and heighten execution risk in its key Chinese corridor.
Form 8-K filing dated 30 Jul 2025 states that Natural Health Trends Corp. (NHTC) has furnished a press release announcing its results for the quarter ended 30 Jun 2025. The information is provided under Item 2.02 – Results of Operations and Financial Condition; however, the filing itself contains no quantitative financial figures. The press release is attached as Exhibit 99.1, and Item 9.01 lists the exhibit together with the Inline XBRL cover-page file (Exhibit 104). The document is signed by CFO Timothy S. Davidson.
FAQ
What is the current stock price of Natural Health Trends (NHTC)?
What is the market cap of Natural Health Trends (NHTC)?
